Lupin has received final approval from USFDA for its Omeprazole delayed-release capsules 40 mg which is market equivalent of AstraZeneca Prilosec delayed-release capsules 40mg. The […]
Aurobindo Pharma has received the final approval from USFDA for Raloxifene Hydrochloride tablets, which is bio-equivalent and therapeutic equivalent to the reference listed drug product […]
Intas Pharmaceuticals planning an expansion programme at its bulk drug manufacturing unit at Matoda village in Ahmedabad district of Gujarat. The project will come up […]
Lupin today has acquired Zao Biocom, a generic pharma company in Russia to make its foray into the Russian market. It is estimated that Russia […]
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]
Hetero Drugs has launched a bio similar drug of Roche ‘s Rituximab, under the brand name Maball in Indian market. Rituximab is a monoclonal antibody […]
SNJ Labs is planning to set up bulk drugs manufacturing unit at Padawala village in Rajkot district in Gujarat. The project cost is estimated at […]
Indoco Remedies is planning an expansion programme at its sterile ophthalmic manufacturing facility in Goa with an investment of Rs. 1250 million. The company is […]
Lupin Limited has signed an agreement to acquire privately held Gavis Pharmaceuticals LLC and Novel Laboratories Inc (Gavis) for a value of USD 880 million. […]
Glaxo Smithline Pharma is planning to set up a new drug plant at Vemgal near Bengaluru with an investment of Rs. 10,000 million. The plant […]
Copyright © 2025 | WordPress Theme by MH Themes